Aethlon Med Inc.
13F holders, Q4 2025 (December 31)8holders +7
8new positions
1sold out
$2.77avg. 13F price*
At the end of Q4 2025, 8 institutions reported holding Aethlon Med Inc. in their 13F filings, up 7 from Q3 2025. 8 opened new positions and 1 sold out. The largest holders were Ikarian Capital, LLC ($40K), Morgan Stanley ($6K) and Citigroup Inc. ($91).
- Company
- Aethlon Med Inc.
- CUSIP
- 00808Y604
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $46K |
| Exits | 1 | $1 |
All 13F filers, Q3 2025 → Q4 2025: 16,478 shares bought and 1 shares sold, net +16,477 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Ikarian Capital, LLC | 0.01% | New | 14,364 | $40K |
| Morgan Stanley | 0.00% | New | 2,047 | $6K |
| Citigroup Inc. | 0.00% | New | 33 | $91 |
| Group One Trading LLC | 0.00% | New | 14 | $39 |
| BlackRock, Inc. | 0.00% | New | 10 | $28 |
| Bank of America Corp. | 0.00% | New | 6 | $17 |
| Wells Fargo & Company | 0.00% | New | 3 | $7 |
| Danske Bank A/S | 0.00% | New | 1 | $3 |
"% of holder's portfolio" is AETHLON MED INC's weight in each manager's 13F, not the share of Aethlon Med Inc. the manager owns.